Drug Metabolism, Pharmacokinetics, and Bioanalysis Intern

Oncology is a key therapeutic area for AbbVie, with a portfolio consisting of three marketed products - Imbruvica, Venclexta, and Empliciti - and a pipeline containing multiple promising new molecules that are being studied in nearly 200 clinical trials in 19 different types of cancer.

AbbVie is expanding its oncology hub on the West Coast, with three sites in the San Francisco Bay Area (Redwood City, South San Francisco, and Sunnyvale) focused on the discovery and development of novel oncology therapies. More than 1,000 AbbVie scientists, clinicians, and product developers with strong entrepreneurial roots work across these three sites. They combine their expertise in immuno-oncology, stem cells, and cell-signaling with their knowledge of bispecific antibodies, antibody-drug conjugates (ADCs), and covalent-inhibitor technologies to discover and develop novel cancer treatments.

Join us for our 2019 Experiential Summer Intern Program!

• Gain hands-on industry experience, work with field experts, and meet other motivated, science-oriented college students like yourself
• Be prepared to work in a well-supported environment, with access to the cutting-edge tools, technologies and expertise
• Learn different aspects of the drug development business, and how it applies to making novel anti-cancer drugs

The AbbVie Experiential Summer Intern Program is a paid, 12 week internship available in two sessions. Session 1 will start at the end of May (semester system) and session 2 will start in early June (quarter system). The program is focused on providing students with original pharmaceutical development projects, based on business need. You'll do meaningful work that has a real impact on our business and patients worldwide.

POSITION DESCRIPTION:

We have two openings in our Drug Metabolism Pharmacokinetics and Bioanalysis group (one in South San Francisco and one in Redwood City). The DMPK group supports Discovery and Development with generation of in vitro ADME data, design of preclinical PK/PD and safety studies, in vivo characterization and analysis of pharmacokinetic (PK) and pharmacodynamic (PD) profiles from preclinical studies, and prediction of human PK/efficacious dose and drug-drug interaction (DDI) for clinical candidates across all therapeutic areas for small and large molecules. Our goal is to deliver high quality in vitro ADME data, influence the design of informative experiments, optimize animal to human translational estimates of the clinical concentrations and regimens likely to be safe and clinically effective.

BASIC REQUIREMENTS:

• Enrolled in an undergraduate level program at an accredited university
• Pursuing a degree in biology, biochemistry, or a related science degree
• Available for the entire 12-weeks in session 1 (semester system) or session 2 (quarter system)
• Completed at least 1 year of undergraduate level studies prior to internship experience
• Strong academic performance with minimum cumulative GPA of 3.0 (4.0 Scale)
• Returning to university for at least 1 semester/quarter post-internship

PREFERRED REQUIREMENTS:

• Demonstrated strong interpersonal skills
• Demonstrated exceptional oral and written communication skills

Equal Opportunity Employer Minorities/Women/Veterans/Disabled